Teva Pharmaceutical Industries Limited Share Price
Stocks
TEVA
US8816242098
Pharmaceuticals
OTC Markets Traded|
Market Closed -
NYSE
21:00:03 02/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 37.49 USD | +3.59% |
|
-1.60% | +20.12% |
| Market Cap | 42.17B 36.4B 34.28B 31.28B 58.39B 4,005B 58.83B 406B 157B 2,037B 158B 155B 6,694B | P/E 2026 * |
48.6x | P/E 2027 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise Value | 54.07B 46.67B 43.96B 40.11B 74.87B 5,135B 75.43B 520B 202B 2,612B 203B 199B 8,583B | EV / Sales 2026 * |
3.26x | EV / Sales 2027 * | 2.94x |
| Free-Float |
88.59% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Teva Pharmaceutical Industries Limited
| 1 day | +3.59% | ||
| 1 week | -1.60% | ||
| Current month | +3.99% | ||
| 1 month | +7.08% | ||
| 3 months | +8.23% | ||
| 6 months | +10.72% | ||
| Current year | +20.12% |
| 1 week | 35.62 | 38.37 | |
| 1 month | 33.78 | 38.37 | |
| Current year | 27.93 | 38.37 | |
| 1 year | 18.21 | 38.37 | |
| 3 years | 8.06 | 38.37 | |
| 5 years | 6.78 | 38.37 | |
| 10 years | 6.07 | 52.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 31/12/2022 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 21/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 02/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 31/12/2008 |
Sol Barer
CHM | Chairman | 78 | 05/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 31/08/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/08/26 | Sell | Controller/Auditor | -14,445 | 0.0012% | ||
| 21/08/26 | Sell | Director | -415 | 0.0000% | ||
| 17/08/26 | Sell | EVP, Business Development | -18,600 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.59% | -1.60% | +103.97% | +281.00% | 42.17B | ||
| +0.01% | -5.96% | +58.36% | +108.23% | 1,034B | ||
| +1.48% | +0.76% | +55.34% | +71.49% | 654B | ||
| +0.67% | -1.53% | +24.39% | +76.60% | 459B | ||
| +0.49% | -6.58% | +34.20% | +34.59% | 343B | ||
| +0.27% | +2.32% | +29.33% | +46.97% | 307B | ||
| +0.12% | -4.01% | +1.06% | +11.93% | 251B | ||
| +1.08% | +0.14% | +53.92% | +72.51% | 237B | ||
| +2.64% | -2.00% | -17.38% | -53.64% | 202B | ||
| -0.21% | +0.56% | +32.43% | +95.19% | 186B | ||
| Average | +0.98% | -3.09% | +37.56% | +74.49% | 371.38B | |
| Weighted average by Cap. | +0.65% | -3.33% | +39.95% | +69.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.59B 14.32B 13.49B 12.31B 22.97B 1,575B 23.14B 160B 61.93B 801B 62.3B 60.94B 2,633B | 17.3B 14.94B 14.07B 12.84B 23.96B 1,643B 24.14B 167B 64.6B 836B 64.98B 63.56B 2,747B |
| Net income | 1.44B 1.24B 1.17B 1.07B 2B 137B 2.01B 13.87B 5.38B 69.61B 5.41B 5.29B 229B | 2.69B 2.32B 2.19B 1.99B 3.72B 255B 3.75B 25.87B 10.04B 130B 10.09B 9.87B 427B |
| Net Debt | 11.9B 10.27B 9.68B 8.83B 16.48B 1,130B 16.6B 115B 44.43B 575B 44.69B 43.72B 1,889B | 8.65B 7.47B 7.03B 6.42B 11.98B 822B 12.07B 83.25B 32.3B 418B 32.49B 31.78B 1,373B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | US$37.49 | +3.59% | 7,660,247 |
| 01/09/26 | US$36.19 | +0.39% | 3,515,716 |
| 31/08/26 | US$36.05 | -1.07% | 5,778,765 |
| 28/08/26 | US$36.44 | -3.14% | 3,140,917 |
| 27/08/26 | US$37.62 | -0.79% | 4,721,594 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions

















